A Novel Cell-Free, Non-Fluorescent Method to Measure LOX-1-Binding Activity Corresponding to The Functional Activity of HDL-Reference-Cited by-同舟云学术

A Novel Cell-Free, Non-Fluorescent Method to Measure LOX-1-Binding Activity Corresponding to The Functional Activity of HDL

Published:2019-11-01 Issue:11 Volume:26 Page:947-958
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Kakino Akemi¹²³,Usami Yoko⁴,Horiuchi Sayaka¹,Fujita Yoshiko¹³,Kotani Kazuhiko⁵,Chen Chu-Huang⁶⁷⁸⁹,Okamura Tomonori¹⁰,Sawamura Tatsuya¹²³⁹

Affiliation:

1. Department of Molecular Pathophysiology, School of Medicine, Shinshu University

2. Institute for Biomedical Sciences, Shinshu University

3. Research Center for Next Generation Medicine, Shinshu University

4. Department of Laboratory Medicine, Shinshu University Hospital

5. Division of Community and Family Medicine, Jichi Medical University

6. Lipid Science and Aging Research Center, Kaohsiung Medical University

7. Vascular and Medicinal Research, Texas Heart Institute

8. Centers for Lipid Biosciences, Kaohsiung Medical University Hospital

9. Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University

10. Department of Preventive Medicine and Public Health, Keio University School of Medicine

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/26/11/26_47183/_pdf

Reference32 articles.

1. 1) Wilkins JT, Ning H, Stone NJ, Criqui MH, Zhao L, Greenland P and Lloyd-Jones DM: Coronary heart disease risks associated with high levels of HDL cholesterol. J Am Heart Assoc, 2014; 3: e000519

2. 2) Hirata A, Okamura T, Sugiyama D, Kuwabara K, Kadota A, Fujiyoshi A, Miura K, Okuda N, Ohkubo T, Okayama A, Ueshima H and Group NDR: The relationship between very high levels of serum high-density lipoprotein cholesterol and cause-specific mortality in a 20-year follow-up study of Japanese general population. J Atheroscler Thromb, 2016; 23: 800-809

3. 3) Ko DT, Alter DA, Guo H, Koh M, Lau G, Austin PC, Booth GL, Hogg W, Jackevicius CA, Lee DS, Wijeysundera HC, Wilkins JT and Tu JV: High-density lipoprotein cholesterol and cause-specific mortality in individuals without previous cardiovascular conditions: The canheart study. J Am Coll Cardiol, 2016; 68: 2073-2083

4. 4) Madsen CM, Varbo A, Tybjaerg-Hansen A, Frikke-Schmidt R and Nordestgaard BG: U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies. Eur Heart J, 2018; 39: 1181-1190

5. 5) Hirata A, Sugiyama D, Watanabe M, Tamakoshi A, Iso H, Kotani K, Kiyama M, Yamada M, Ishikawa S, Murakami Y, Miura K, Ueshima H, Okamura T and Evidence for Cardiovascular Prevention from Observational Cohorts in Japan Research G: Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH-JAPAN study. J Clin Lipidol, 2018; 12: 674-684 e675

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atherosclerosis Calcification: Focus on Lipoproteins;Metabolites;2023-03-21

2. Serum modified high-density lipoprotein and risk of atherosclerotic cardiovascular disease in a Japanese community-based nested case–control study;European Journal of Preventive Cardiology;2021-09-02

3. Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease?;Biomedicines;2021-05-16

4. Adiponectin forms a complex with atherogenic LDL and inhibits its downstream effects;Journal of Lipid Research;2021

5. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a crucial driver of atherosclerotic cardiovascular disease;European Heart Journal;2020-11-07